Proton Pump Inhibitors Market is Estimated to Witness High Growth Owing to Opportunity to Treat Various Digestive Disorders
![]() |
Proton Pump Inhibitors Market |
Proton
pump inhibitors (PPIs) are a type of medication that work by reducing the
amount of acid produced in the stomach. PPIs are used to treat various
acid-related disorders including erosive esophagitis, symptomatic
gastroesophageal reflux disease, duodenal and gastric ulcers caused by
Helicobacter pylori, and Zollinger-Ellison syndrome. Some common PPI
medications include omeprazole, esomeprazole, lansoprazole, rabeprazole, and
pantoprazole. The global proton pump inhibitors market size is estimated to be
valued at US$ 3.29 Bn in 2023 and is expected to exhibit a CAGR of 10% over the
forecast period 2023 to 2030, as highlighted in a new report published by
Coherent Market Insights.
Market Opportunity
The key growth opportunity for the proton pump inhibitors market lies in
increasing prevalence of digestive disorders. According to the findings of
International Foundation for Functional Gastrointestinal Disorders, over 60
million Americans are affected by digestive diseases each year. Digestive and
liver diseases are the third leading cause of disease burden in America. The
burden and costs of acid-related gastrointestinal disorders and
gastrointestinal ulcers is significant worldwide. PPI drugs have been gaining
significant popularity in recent years for effective treatment and management
of such disorders. Increasing awareness about PPI drugs and their advantages
over traditional antacids is expected to fuel market growth over the forecast
period.
Porter’s Analysis
Threat of new entrants: The threat of new entrants is moderate as the industry
requires high R&D investments for product development. However, low
differentiation between existing products allows scope for new players.
Bargaining power of buyers: The bargaining power of buyers is high given the
availability of generic PPIs and presence of many established manufacturers
providing treatment options. Buyers can negotiate on price.
Bargaining power of suppliers: The bargaining power of suppliers is moderate as
raw materials for PPI manufacturing are commodity chemicals freely available
from multiple suppliers.
Threat of new substitutes: Threat of new substitutes is low as currently there
are limited treatment options for acid reflux and ulcers available.
Competitive rivalry: The competitive rivalry is high among key players to gain
market share through product innovation and investment in marketing.
SWOT Analysis
Strength: PPIs are highly effective drugs for acid reflux treatment.
Established drug delivery and strong distribution networks of key players.
Weakness: Long term PPI usage can cause side effects like kidney damage and
bone fractures. Rising generic competition impacts brand names.
Opportunity: Large patient pool for gastric acid related diseases offers scope
to penetrate newer regions. Combination therapy with antibiotics and
development of delayed-release formulations can boost growth.
Threats: Safety concerns over long term use and rising awareness about side
effects negatively impacts the market. Strong regulatory norms for new drug
approvals pose challenges.
Key Takeaways
The Global
Proton Pump Inhibitors Market Share is expected to witness high growth
over the forecast period of 2023-2030 supported by rising geriatric population
susceptible to acid reflux diseases.
The North American region currently dominates the PPI market owing to high
treatment adoption rates and developed healthcare infrastructure. However, Asia
Pacific is poised to witness fastest growth during the forecast period. Factors
such as rising healthcare spending, large patient population and increasing
medical tourism will boost the Asia Pacific PPI market.
Key players operating in the proton pump inhibitors market are Koninklijke
TenCate (Netherlands), Low & Bonar (UK), Fibertex Nonwovens (Denmark),
Thrace Group (Greece), Huesker (Germany), Berry Global (US), DuPont (US),
Strata Systems (US), Leggett & Platt (US), Officine Maccaferri (Italy), GSE
Environmental (US), Kaytech (South Africa), Mattex (Saudi Arabia), NAUE
(Germany), Propex Operating Company (US), Carthage Mills (US), and Asahi Kasei
Advance Corporation (Japan), among others. The market is moderately
consolidated with top players competing on the basis of their portfolio, brand
value and pricing.
For
more details on the report, Read- https://www.pressreleasebulletin.com/proton-pump-inhibitors-market-demand-share-analysis/
Comments
Post a Comment